Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Deferred Tax (2016 - 2020)

Historic Long-Term Deferred Tax for ENDRA Life Sciences (NDRA) over the last 5 years, with Q4 2020 value amounting to $11.3 million.

  • ENDRA Life Sciences' Long-Term Deferred Tax rose 4431.83% to $11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $11.3 million, marking a year-over-year increase of 4431.83%. This contributed to the annual value of $11.3 million for FY2020, which is 4431.83% up from last year.
  • Per ENDRA Life Sciences' latest filing, its Long-Term Deferred Tax stood at $11.3 million for Q4 2020, which was up 4431.83% from $7.8 million recorded in Q4 2019.
  • Over the past 5 years, ENDRA Life Sciences' Long-Term Deferred Tax peaked at $11.3 million during Q4 2020, and registered a low of $3.8 million during Q4 2016.
  • Over the past 5 years, ENDRA Life Sciences' median Long-Term Deferred Tax value was $6.6 million (recorded in 2018), while the average stood at $6.7 million.
  • Per our database at Business Quant, ENDRA Life Sciences' Long-Term Deferred Tax skyrocketed by 575.09% in 2017 and then surged by 6412.0% in 2018.
  • Over the past 5 years, ENDRA Life Sciences' Long-Term Deferred Tax (Quarter) stood at $3.8 million in 2016, then increased by 5.75% to $4.0 million in 2017, then soared by 64.12% to $6.6 million in 2018, then increased by 18.49% to $7.8 million in 2019, then surged by 44.32% to $11.3 million in 2020.
  • Its last three reported values are $11.3 million in Q4 2020, $7.8 million for Q4 2019, and $6.6 million during Q4 2018.